(0.22%) 5 533.50 points
(0.13%) 39 520 points
(0.25%) 19 978 points
(0.80%) $82.19
(-1.04%) $2.57
(-0.21%) $2 334.60
(-0.22%) $29.50
(0.37%) $1 005.60
(-0.46%) $0.929
(-0.63%) $10.61
(-0.22%) $0.789
(1.63%) $87.12
Live Chart Being Loaded With Signals
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, consumer, and animal care products in Australia and New Zealand...
Stats | |
---|---|
Dagens volum | 34 183 |
Gjennomsnittsvolum | 47 280 |
Markedsverdi | 5.68B |
EPS | $0.710 ( Q2 | 2023-12-31 ) |
Neste inntjeningsdato | ( $0 ) 2024-07-09 |
Last Dividend | $0.468 ( 2024-02-29 ) |
Next Dividend | $0 ( N/A ) |
P/E |
21.92 (Sector) 0 (Industry) 0 |
ATR14 | $0.0150 (0.05%) |
Volum Korrelasjon
EBOS Group Ltd Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
EBOS Group Ltd Korrelasjon - Valuta/Råvare
EBOS Group Ltd Økonomi
Annual | 2023 |
Omsetning: | $13.32B |
Bruttogevinst: | $1.70B (12.76 %) |
EPS: | $1.450 |
FY | 2023 |
Omsetning: | $13.32B |
Bruttogevinst: | $1.70B (12.76 %) |
EPS: | $1.450 |
FY | 2022 |
Omsetning: | $11.90B |
Bruttogevinst: | $1.38B (11.60 %) |
EPS: | $1.270 |
FY | 2021 |
Omsetning: | $9.89B |
Bruttogevinst: | $1.07B (10.78 %) |
EPS: | $1.232 |
Financial Reports:
No articles found.
EBOS Group Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.380 (N/A) |
$0 (N/A) |
$0.426 (N/A) |
$0 (N/A) |
$0.471 (N/A) |
$0 (N/A) |
$0.468 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.178 | 2014-03-07 |
Last Dividend | $0.468 | 2024-02-29 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 21 | -- |
Total Paid Out | $6.56 | -- |
Avg. Dividend % Per Year | 2.01% | -- |
Score | 3.92 | -- |
Div. Sustainability Score | 8.16 | |
Div.Growth Potential Score | 4.56 | |
Div. Directional Score | 6.36 | -- |
Year | Amount | Yield |
---|---|---|
2014 | $0.383 | 4.67% |
2015 | $0.390 | 4.11% |
2016 | $0.484 | 3.87% |
2017 | $0.514 | 3.23% |
2018 | $0.615 | 3.69% |
2019 | $0.600 | 3.06% |
2020 | $0.693 | 3.00% |
2021 | $0.746 | 2.67% |
2022 | $0.772 | 1.99% |
2023 | $0.897 | 2.18% |
2024 | $0.468 | 1.41% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
29 Feb 2024 | $0.468 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
07 Sep 2023 | $0.471 | 30 Nov -0001 | 08 Sep 2023 | 29 Sep 2023 |
02 Mar 2023 | $0.426 | 30 Nov -0001 | 03 Mar 2023 | 17 Mar 2023 |
08 Sep 2022 | $0.380 | 30 Nov -0001 | 09 Sep 2022 | 30 Sep 2022 |
03 Mar 2022 | $0.392 | 30 Nov -0001 | 04 Mar 2022 | 18 Mar 2022 |
09 Sep 2021 | $0.395 | 30 Nov -0001 | 10 Sep 2021 | 24 Sep 2021 |
04 Mar 2021 | $0.351 | 30 Nov -0001 | 05 Mar 2021 | 18 Mar 2021 |
24 Sep 2020 | $0.329 | 30 Nov -0001 | 25 Sep 2020 | 09 Oct 2020 |
12 Mar 2020 | $0.364 | 20 Feb 2020 | 13 Mar 2020 | 03 Apr 2020 |
26 Sep 2019 | $0.308 | 22 Aug 2019 | 27 Sep 2019 | 11 Oct 2019 |
14 Mar 2019 | $0.292 | 20 Feb 2019 | 15 Mar 2019 | 05 Apr 2019 |
27 Sep 2018 | $0.338 | 23 Aug 2018 | 28 Sep 2018 | 12 Oct 2018 |
15 Mar 2018 | $0.277 | 21 Feb 2018 | 16 Mar 2018 | 06 Apr 2018 |
28 Sep 2017 | $0.266 | 24 Aug 2017 | 29 Sep 2017 | 13 Oct 2017 |
16 Mar 2017 | $0.248 | 22 Feb 2017 | 17 Mar 2017 | 07 Apr 2017 |
29 Sep 2016 | $0.270 | 25 Aug 2016 | 30 Sep 2016 | 14 Oct 2016 |
10 Mar 2016 | $0.214 | 24 Feb 2016 | 11 Mar 2016 | 01 Apr 2016 |
30 Sep 2015 | $0.202 | 26 Aug 2015 | 02 Oct 2015 | 16 Oct 2015 |
11 Mar 2015 | $0.188 | 25 Feb 2015 | 13 Mar 2015 | 02 Apr 2015 |
01 Oct 2014 | $0.205 | 27 Aug 2014 | 03 Oct 2014 | 17 Oct 2014 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
EZL.AX | Dividend Royal | 2024-02-02 | Semi-Annually | 24 | 11.64% | 8.24 |
GRR.AX | Dividend Royal | 2024-03-12 | Semi-Annually | 14 | 11.88% | 7.99 |
RKN.AX | Dividend Royal | 2023-08-31 | Annually | 22 | 15.73% | 7.24 |
TWR.AX | Dividend King | 2024-06-12 | Annually | 25 | 5.98% | 7.21 |
YAL.AX | Dividend Royal | 2024-03-12 | Annually | 7 | 12.76% | 7.18 |
SHM.AX | Dividend Royal | 2024-03-14 | Semi-Annually | 9 | 14.97% | 7.14 |
HZN.AX | Dividend Royal | 2024-04-18 | Semi-Annually | 4 | 18.99% | 7.06 |
BHP.AX | Dividend Royal | 2024-03-07 | Semi-Annually | 37 | 6.46% | 6.97 |
CDD.AX | Ex Dividend King | 2024-05-24 | Annually | 21 | 91.43% | 6.79 |
KSL.AX | Dividend Royal | 2024-03-05 | Semi-Annually | 9 | 9.58% | 6.77 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0203 | 1.500 | 9.59 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0367 | 1.200 | 8.78 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0972 | 1.500 | -0.0316 | -0.0474 | [0.1 - 1] |
payoutRatioTTM | 0.823 | -1.000 | 1.770 | -1.770 | [0 - 1] |
currentRatioTTM | 1.131 | 0.800 | 9.34 | 7.48 | [1 - 3] |
quickRatioTTM | 0.643 | 0.800 | -0.923 | -0.738 | [0.8 - 2.5] |
cashRatioTTM | 0.0797 | 1.500 | -0.668 | -1.002 | [0.2 - 2] |
debtRatioTTM | 0.199 | -1.500 | 6.68 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 5.16 | 1.000 | 9.20 | 9.20 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.734 | 2.00 | 9.42 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.063 | 2.00 | 9.47 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.527 | -1.500 | 7.89 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0737 | 1.000 | -2.11 | -2.11 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0367 | 1.000 | -1.266 | -1.266 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.238 | 1.000 | 9.79 | 9.79 | [0.2 - 2] |
assetTurnoverTTM | 1.809 | 0.800 | 1.270 | 1.016 | [0.5 - 2] |
Total Score | 8.16 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 21.91 | 1.000 | 7.89 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0972 | 2.50 | -0.0203 | -0.0474 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.063 | 2.00 | 9.65 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.19 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.734 | 2.00 | 9.42 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.823 | 1.500 | 1.770 | -1.770 | [0 - 1] |
pegRatioTTM | 1.307 | 1.500 | 4.62 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0262 | 1.000 | -1.844 | 0 | [0.1 - 0.5] |
Total Score | 4.56 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
EBOS Group Ltd
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, consumer, and animal care products in Australia and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and multi-brand retail pharmacy services. It also offers vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; community based health care services and programs; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers contract logistics services, such as healthcare distribution, warehousing, clinical trial management, and product registration services; and clinical trial logistics. Additionally, the company provides pet nutrition products, treats, clean-up products, grooming, and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.